Protocols
3 protocol(s) meet the specified criteria
Drug: Fulvestrant
Protocol No.TitleStatus
ALTERNATE/A011106ALTernate approaches for clinical stage II or III Estrogen Receptor positive breast cancer NeoAdjuvant TrEatment (ALTERNATE) in postmenopausal women: A Phase III StudyOpen
MM-121-02-02-10SHERBOC: A Double-blind, Placebo-controlled, Phase 2 trial of Seribantumab Plus Fulvestrant in Postmenopausal Women with Hormone Receptor-positive, Heregulin Positive (HRG+), HER2 Negative Metastatic Breast Cancer Whose Disease Progressed After Prior Systemic TherapyOpen
TBCRC-037A Trial of Endocrine Response in Women with Invasive Lobular Breast CancerOpen